Form D · Other Health Care

Olympus Topco, Inc.

New York, NY · CIK 0001683269

Offering snapshot reported Sep 16, 2016 · SEC filing

Reported sold
$18.3M
Indefinite offering
Investors reported
11
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 29, 2016
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Sep 16, 2016Initial$18,250,700No comparison11SEC filing

Offering details

Securities
Equity, Option to acquire, Security to be acquired
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-270796
This filing relates to issuances under the Olympus Topco, Inc. 2015 Stock Option Plan at prices determined at the time of grant. For this purpose, Options are valued at their exercise price. Does not reflect grants, if any, pursuant to Rule 701.

Source: Form D, filed Sep 16, 2016. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Matthew Bennett Director, Executive
Jeremy Delinsky Director
Jeff Hammerbacher Director
Matthew S. Holt Director, Executive
Paxton Jevnick Director
Albert Notini Director, Executive
Kyle Peterson Executive
Timothy Poehling Director
Jack Qian Director
Lori Reel Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
787 Seventh Avenue 49 Th Floor
New York, NY, 10019